Efficacy of osimertinib in patients with lung cancer positive for uncommon EGFR exon 19 deletion mutations. Grant MJ, Aredo JV, Starrett JH, Stockhammer P, et al. Clin Cancer Res 2023 Mar 13:CCR-22-3497. doi: 10.1158/1078-0432.CCR-22-3497.

Read + Share

Amedeo Smart

Independent Medical Education

Grant MJ, Aredo JV, Starrett JH, Stockhammer P, et al. Efficacy of osimertinib in patients with lung cancer positive for uncommon EGFR exon 19 deletion mutations. Clin Cancer Res 2023 Mar 13:CCR-22-3497. doi: 10.1158/1078-0432.CCR-22-3497.
PMID: 36913537